Priority Date: 10.09.12 (US 201261699071P)

INDIVIDUALIZED IMMUNOMODULATION THERAPY FOR NEURODEGENERATIVE DISORDERS, CNS INJURY AND AGE-RELATED DEMENTIA

  • Application ID: EP13836112
  • Status: GRANT OF PATENT INTENDED

Applicant

Company dna yeda research and development co ltd
Technology Transfer Office

Attorneys

no operation time available
1030.28
1 office
active in Legal Services
no operation time available
1093.01
2 offices
active in Legal Services

Specialization

This patent has the IPC combination A01, A61, and G01 is specialized in the combination A01, A61, and G01. We found, that Coller IP Management Ltd, dompatent von Kreisler Selting Werner - Partnerschaft von Patent- und Rechtsanwälten mbB, Vereenigde Octrooibureaux NV (V.O.), ip21 Ltd, KOPPEL patendibüroo OÜ and 32 others are specialized in all of these IPC classes. For a similar patent, they might be a good choice.

Timeline

  • 10.09.2012 - Priority Date (US 201261699071P)
  • 13.03.2014 - Publication A1 (WO2014037952)
  • 15.07.2015 - Publication A1 (EP2892353)

IPC Classification